Shikonin (Shik), a natural pigment, has received growing
interest
in various biomedical fields due to its anti-inflammatory, antitumor,
antimicrobial, and antioxidant ability. However, some inherent characteristics
of Shik, such as its virulence, low bioavailability, and poor solubility,
have limited its biomedical applicability. Here, we reported a facile
synthetic method to produce the Shik-iron (III) nanoparticles (Shik-Fe
NPs), which could overcome these limitations of Shik. The synthesized
Shik-Fe NPs possessed a uniform size range of 110 ± 10 nm, negative
surface charges, good water dispersity, and high safety. Iron distributed
uniformly inside Shik-Fe NPs, and iron constituted 20% of total mass
in PEGylated Shik-Fe NPs. When interacting with activated macrophages,
Shik-Fe NPs significantly reduced the level of cellular inflammatory
factors, for example, iNOS, IL-1β, and TNF-α. Furthermore,
the Shik-Fe NPs demonstrated synergistic anti-inflammation and anti-bacterial
properties in vivo, since they could release Fe3+ and Shik
to eradicate bacteria (Staphylococcus aureus and P. aeruginosa were used as model
microbes here) during wound infections and provide full recovery for
scald wounds. Collectively, the study established a dual-functional
Shik-derived nanoplatform, which could be useful for the treatment
of various inflammation-involved diseases.